BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Position in NBIX — Neurocrine Biosciences Inc
CIK 842180
Madrid, U3
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$202,879
-$20,951,916 QoQ
Shares Held
1,540
-99.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANCO BILBAO VIZCAYA ARGENTARIA, S.A. holds $13,535,547 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
142,241 | $5,368,175 | |
| 2 | VTRS |
Viatris Inc
|
280,376 | $3,787,879 | |
| 3 | ZTS |
Zoetis Inc.
|
30,722 | $3,631,647 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
610 | $361,717 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,540 | $202,879 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
19,249 | $183,250 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,879 | 1,540 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $21,154,795 | 149,156 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,746,619 | 147,789 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,587,037 | 147,880 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,856,611 | 143,369 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,064,955 | 139,670 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,987,351 | 138,755 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $19,102,400 | 138,755 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $19,137,089 | 138,755 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,282,358 | 138,755 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,609,937 | 138,755 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $13,084,596 | 138,755 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $13,536,454 | 133,733 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $15,973,069 | 133,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,203,781 | 133,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,036,292 | 133,733 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $12,537,468 | 133,733 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $11,390,039 | 133,733 | Shares | Defined | 2022-02-15 | |
| 2020-06-30 | $610,000 | 5,000 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $432,750 | 5,000 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||